Merck (MRK)

• Market cap: $322B
• 1 day: -0.38%
• 5 days: 0.78%
• 1 month: 5.15%
• 3 months: 17.2%
• 6 months: 9.31%
• Year to date: 22.52%
• 1 year: 62.96%
• 5 years: 73.41%
• 10 years: 114.79%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000